AGIO:NASDAQ
Agios Pharmaceuticals Inc
$33.07
arrow_downward
-1.61%(-0.54) 1D
$32.42
arrow_downward
-1.96% (-0.65)bedtimePagkalipas ng oras ng trabaho
Sarado: Set 18, 4:00:01 PM GMT-4 · USD
search
Lahat ng simbolo
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa AGIO...
Buksan
$33.29
Mataas
$33.40
Mababa
$32.77
Mkt. cap
1.97B
Avg. na dami
926.77K
Dami
1.57M
Mataas nang 52-wk
$45.99
Mababa nang 52-wk
$22.24
EPS
-$7.01
Beta
0.60
Mga natitirang share
59.70M
Bilang ng mga empleyado
540
Buksan
$33.29
Mataas
$33.40
Mababa
$32.77
Mkt. cap
1.97B
Avg. na dami
926.77K
Dami
1.57M
Mataas nang 52-wk
$45.99
Mababa nang 52-wk
$22.24
EPS
-$7.01
Beta
0.60
Mga natitirang share
59.70M
Bilang ng mga empleyado
540
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
CarePlus VietNam
·
3 linggo ang nakalipas
AGIO Q2 2026 Earnings: Narrower-Than-Expected Loss Fails to Halt Share Decline - Profit Inflection Point
CarePlus VietNam
·
1 buwan ang nakalipas
AGIO Q2 2026 Earnings: Narrower-Than-Expected Loss Lifts Shares 0.73% - Tangible Book Value
CarePlus VietNam
·
1 buwan ang nakalipas
AGIO Q1 2026 Earnings: Narrowed Loss Beats Estimates as Pipeline Advances - Revenue Warning Signal
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
Tungkol sa Agios Pharmaceuticals Inc